LakeShore Biopharma Co Ltd
LSB0.627USD
0.0000.00%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
13.02M시가총액
--P/E TTM
자세한 내용은 LakeShore Biopharma Co Ltd 회사
LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
LakeShore Biopharma Co Ltd 정보
종목 코드 LSB
회사 이름LakeShore Biopharma Co Ltd
상장일Jul 30, 2021
CEOMr. Dave Chenn
직원 수573
유형Ordinary Share
회계 연도 종료Jul 30
주소Building No. 2, 38 Yongda Road
도시BEIJING
증권 거래소NASDAQ Capital Market Consolidated
국가China
우편 번호102629
전화
웹사이트https://www.ysbiopharm.com/
종목 코드 LSB
상장일Jul 30, 2021
CEOMr. Dave Chenn
LakeShore Biopharma Co Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Mr. Gang Li
Mr. Gang Li
Head of Marketing and sales
Head of Marketing and sales
--
--
Dr. Stanley Yi Chang
Dr. Stanley Yi Chang
Independent Director
Independent Director
--
--
Dr. Ajit Shetty
Dr. Ajit Shetty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Thomas Xue
Mr. Thomas Xue
Director
Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sun, Nov 16
마지막 업데이트: Sun, Nov 16
주주
주주 유형
주주
주주
비율
Crystal Peak Investment Inc
51.01%
Apex Prospect Ltd
23.87%
Zhang (Yi)
11.91%
Oceanpine Capital
1.12%
Shao (Hui)
0.76%
기타
11.33%
주주
주주
비율
Crystal Peak Investment Inc
51.01%
Apex Prospect Ltd
23.87%
Zhang (Yi)
11.91%
Oceanpine Capital
1.12%
Shao (Hui)
0.76%
기타
11.33%
주주 유형
주주
비율
Corporation
75.75%
Individual Investor
12.67%
Investment Advisor
1.18%
Private Equity
0.27%
Investment Advisor/Hedge Fund
0.07%
기타
10.05%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
19
631.21K
1.53%
-1.57M
2025Q3
20
323.47K
0.78%
-1.42M
2025Q2
28
16.97M
69.54%
+11.06M
2025Q1
32
16.97M
88.94%
+11.13M
2024Q4
63
15.91M
83.38%
+8.88M
2024Q3
69
15.84M
83.04%
+8.47M
2024Q2
74
16.03M
84.03%
+8.50M
2024Q1
78
15.49M
82.30%
+7.79M
2023Q4
79
6.05M
65.03%
-1.81M
2023Q3
78
6.62M
71.14%
+3.69M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Crystal Peak Investment Inc
21.02M
51.01%
--
--
Nov 04, 2025
Apex Prospect Ltd
9.84M
23.87%
+1.00
+0.00%
Jul 11, 2025
Zhang (Yi)
4.91M
11.91%
--
--
Jun 30, 2025
Oceanpine Capital
462.76K
1.12%
--
--
Nov 04, 2025
Shao (Hui)
313.64K
0.76%
--
--
Jun 30, 2025
Adjuvant Capital LP
290.30K
0.7%
--
--
Nov 04, 2025
MSA Capital
112.90K
0.27%
--
--
Nov 04, 2025
Epiphron Capital (Hong Kong) Ltd
70.08K
0.17%
--
--
Nov 04, 2025
Superstring Capital Management LP
30.79K
0.07%
--
--
Nov 04, 2025
Barclays Bank PLC
24.76K
0.06%
--
--
Sep 30, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Sep 27, 2024
Merger
10→1
Sep 27, 2024
Merger
10→1
Sep 27, 2024
Merger
10→1
Sep 27, 2024
Merger
10→1
날짜
배당락일
유형
비율
Sep 27, 2024
Merger
10→1
Sep 27, 2024
Merger
10→1
Sep 27, 2024
Merger
10→1
Sep 27, 2024
Merger
10→1
